Glucose-Lowering Drugs Linked to Increased Fracture Risk in Patients With Diabetes

Researchers in Denmark have concluded that use of glucose-lowering sulfonylureas and glitazones within 90 days increased the risk for hip fractures in elderly patients with type 2 diabetes.
Source: Caring for the Ages - Category: Health Management Authors: Source Type: news